Eintrag weiter verarbeiten
Verfügbar über Online-Ressource

A derivative of staurosporine (CGP 41:251) shows selectivity for PKC inhibition and in vitro antiproliferative effects as well as in vivo antitumor activity. Int. J. Cancer, 43, 85...

Gespeichert in:

Bibliographische Detailangaben
Zeitschriftentitel: International Journal of Cancer
Personen und Körperschaften: Meyer, T., Regenass, U., Fabbro, D., Alteri, E., Rösel, J., Müller, M., Caravatti, G., Matter, A.
In: International Journal of Cancer, 81, 1999, 4, S. 669-669
Format: E-Article
Sprache: Unbestimmt
veröffentlicht:
Wiley
Schlagwörter:
Cancer Research
Oncology
author_facet Meyer, T.
Regenass, U.
Fabbro, D.
Alteri, E.
Rösel, J.
Müller, M.
Caravatti, G.
Matter, A.
Meyer, T.
Regenass, U.
Fabbro, D.
Alteri, E.
Rösel, J.
Müller, M.
Caravatti, G.
Matter, A.
author Meyer, T.
Regenass, U.
Fabbro, D.
Alteri, E.
Rösel, J.
Müller, M.
Caravatti, G.
Matter, A.
spellingShingle Meyer, T.
Regenass, U.
Fabbro, D.
Alteri, E.
Rösel, J.
Müller, M.
Caravatti, G.
Matter, A.
International Journal of Cancer
A derivative of staurosporine (CGP 41:251) shows selectivity for PKC inhibition and in vitro antiproliferative effects as well as in vivo antitumor activity. Int. J. Cancer, 43, 851–866 (1989)
Cancer Research
Oncology
author_sort meyer, t.
spelling Meyer, T. Regenass, U. Fabbro, D. Alteri, E. Rösel, J. Müller, M. Caravatti, G. Matter, A. 0020-7136 1097-0215 Wiley Cancer Research Oncology http://dx.doi.org/10.1002/(sici)1097-0215(19990517)81:4<669::aid-ijc26>3.3.co;2-6 A derivative of staurosporine (CGP 41:251) shows selectivity for PKC inhibition and in vitro antiproliferative effects as well as in vivo antitumor activity. Int. J. Cancer, 43, 851–866 (1989) International Journal of Cancer
doi_str_mv 10.1002/(sici)1097-0215(19990517)81:4<669::aid-ijc26>3.3.co;2-6
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi8oc2ljaSkxMDk3LTAyMTUoMTk5OTA1MTcpODE6NDw2Njk6OmFpZC1pamMyNj4zLjMuY287Mi02
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi8oc2ljaSkxMDk3LTAyMTUoMTk5OTA1MTcpODE6NDw2Njk6OmFpZC1pamMyNj4zLjMuY287Mi02
institution DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-D161
DE-Zwi2
DE-Gla1
DE-Zi4
imprint Wiley, 1999
imprint_str_mv Wiley, 1999
issn 0020-7136
1097-0215
issn_str_mv 0020-7136
1097-0215
language Undetermined
mega_collection Wiley (CrossRef)
match_str meyer1999aderivativeofstaurosporinecgp41251showsselectivityforpkcinhibitionandinvitroantiproliferativeeffectsaswellasinvivoantitumoractivityintjcancer438518661989
publishDateSort 1999
publisher Wiley
recordtype ai
record_format ai
series International Journal of Cancer
source_id 49
title A derivative of staurosporine (CGP 41:251) shows selectivity for PKC inhibition and in vitro antiproliferative effects as well as in vivo antitumor activity. Int. J. Cancer, 43, 851–866 (1989)
title_unstemmed A derivative of staurosporine (CGP 41:251) shows selectivity for PKC inhibition and in vitro antiproliferative effects as well as in vivo antitumor activity. Int. J. Cancer, 43, 851–866 (1989)
title_full A derivative of staurosporine (CGP 41:251) shows selectivity for PKC inhibition and in vitro antiproliferative effects as well as in vivo antitumor activity. Int. J. Cancer, 43, 851–866 (1989)
title_fullStr A derivative of staurosporine (CGP 41:251) shows selectivity for PKC inhibition and in vitro antiproliferative effects as well as in vivo antitumor activity. Int. J. Cancer, 43, 851–866 (1989)
title_full_unstemmed A derivative of staurosporine (CGP 41:251) shows selectivity for PKC inhibition and in vitro antiproliferative effects as well as in vivo antitumor activity. Int. J. Cancer, 43, 851–866 (1989)
title_short A derivative of staurosporine (CGP 41:251) shows selectivity for PKC inhibition and in vitro antiproliferative effects as well as in vivo antitumor activity. Int. J. Cancer, 43, 851–866 (1989)
title_sort a derivative of staurosporine (cgp 41:251) shows selectivity for pkc inhibition and in vitro antiproliferative effects as well as in vivo antitumor activity. int. j. cancer, 43, 851–866 (1989)
topic Cancer Research
Oncology
url http://dx.doi.org/10.1002/(sici)1097-0215(19990517)81:4<669::aid-ijc26>3.3.co;2-6
publishDate 1999
physical 669-669
description
container_issue 4
container_start_page 669
container_title International Journal of Cancer
container_volume 81
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792347803849064451
geogr_code not assigned
last_indexed 2024-03-01T18:01:06.295Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=A+derivative+of+staurosporine+%28CGP+41%3A251%29+shows+selectivity+for+PKC+inhibition+and+in+vitro+antiproliferative+effects+as+well+as+in+vivo+antitumor+activity.+Int.+J.+Cancer%2C+43%2C+851%E2%80%93866+%281989%29&rft.date=1999-05-17&genre=article&issn=1097-0215&volume=81&issue=4&spage=669&epage=669&pages=669-669&jtitle=International+Journal+of+Cancer&atitle=A+derivative+of+staurosporine+%28CGP+41%3A251%29+shows+selectivity+for+PKC+inhibition+and+in+vitro+antiproliferative+effects+as+well+as+in+vivo+antitumor+activity.+Int.+J.+Cancer%2C+43%2C+851%E2%80%93866+%281989%29&aulast=Matter&aufirst=A.&rft_id=info%3Adoi%2F10.1002%2F%28sici%291097-0215%2819990517%2981%3A4%3C669%3A%3Aaid-ijc26%3E3.3.co%3B2-6&rft.language%5B0%5D=und
SOLR
_version_ 1792347803849064451
author Meyer, T., Regenass, U., Fabbro, D., Alteri, E., Rösel, J., Müller, M., Caravatti, G., Matter, A.
author_facet Meyer, T., Regenass, U., Fabbro, D., Alteri, E., Rösel, J., Müller, M., Caravatti, G., Matter, A., Meyer, T., Regenass, U., Fabbro, D., Alteri, E., Rösel, J., Müller, M., Caravatti, G., Matter, A.
author_sort meyer, t.
container_issue 4
container_start_page 669
container_title International Journal of Cancer
container_volume 81
description
doi_str_mv 10.1002/(sici)1097-0215(19990517)81:4<669::aid-ijc26>3.3.co;2-6
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi8oc2ljaSkxMDk3LTAyMTUoMTk5OTA1MTcpODE6NDw2Njk6OmFpZC1pamMyNj4zLjMuY287Mi02
imprint Wiley, 1999
imprint_str_mv Wiley, 1999
institution DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-D161, DE-Zwi2, DE-Gla1, DE-Zi4
issn 0020-7136, 1097-0215
issn_str_mv 0020-7136, 1097-0215
language Undetermined
last_indexed 2024-03-01T18:01:06.295Z
match_str meyer1999aderivativeofstaurosporinecgp41251showsselectivityforpkcinhibitionandinvitroantiproliferativeeffectsaswellasinvivoantitumoractivityintjcancer438518661989
mega_collection Wiley (CrossRef)
physical 669-669
publishDate 1999
publishDateSort 1999
publisher Wiley
record_format ai
recordtype ai
series International Journal of Cancer
source_id 49
spelling Meyer, T. Regenass, U. Fabbro, D. Alteri, E. Rösel, J. Müller, M. Caravatti, G. Matter, A. 0020-7136 1097-0215 Wiley Cancer Research Oncology http://dx.doi.org/10.1002/(sici)1097-0215(19990517)81:4<669::aid-ijc26>3.3.co;2-6 A derivative of staurosporine (CGP 41:251) shows selectivity for PKC inhibition and in vitro antiproliferative effects as well as in vivo antitumor activity. Int. J. Cancer, 43, 851–866 (1989) International Journal of Cancer
spellingShingle Meyer, T., Regenass, U., Fabbro, D., Alteri, E., Rösel, J., Müller, M., Caravatti, G., Matter, A., International Journal of Cancer, A derivative of staurosporine (CGP 41:251) shows selectivity for PKC inhibition and in vitro antiproliferative effects as well as in vivo antitumor activity. Int. J. Cancer, 43, 851–866 (1989), Cancer Research, Oncology
title A derivative of staurosporine (CGP 41:251) shows selectivity for PKC inhibition and in vitro antiproliferative effects as well as in vivo antitumor activity. Int. J. Cancer, 43, 851–866 (1989)
title_full A derivative of staurosporine (CGP 41:251) shows selectivity for PKC inhibition and in vitro antiproliferative effects as well as in vivo antitumor activity. Int. J. Cancer, 43, 851–866 (1989)
title_fullStr A derivative of staurosporine (CGP 41:251) shows selectivity for PKC inhibition and in vitro antiproliferative effects as well as in vivo antitumor activity. Int. J. Cancer, 43, 851–866 (1989)
title_full_unstemmed A derivative of staurosporine (CGP 41:251) shows selectivity for PKC inhibition and in vitro antiproliferative effects as well as in vivo antitumor activity. Int. J. Cancer, 43, 851–866 (1989)
title_short A derivative of staurosporine (CGP 41:251) shows selectivity for PKC inhibition and in vitro antiproliferative effects as well as in vivo antitumor activity. Int. J. Cancer, 43, 851–866 (1989)
title_sort a derivative of staurosporine (cgp 41:251) shows selectivity for pkc inhibition and in vitro antiproliferative effects as well as in vivo antitumor activity. int. j. cancer, 43, 851–866 (1989)
title_unstemmed A derivative of staurosporine (CGP 41:251) shows selectivity for PKC inhibition and in vitro antiproliferative effects as well as in vivo antitumor activity. Int. J. Cancer, 43, 851–866 (1989)
topic Cancer Research, Oncology
url http://dx.doi.org/10.1002/(sici)1097-0215(19990517)81:4<669::aid-ijc26>3.3.co;2-6